Pharmaceutical

Leo Pharma to acquire US company Timber Pharmaceuticals

Leo Pharma has entered an agreement for the acquisition of US-based clinical-stage biopharma firm Timber Pharmaceuticals for $36m.

Aug 22, 2023 - 20:00
Leo Pharma to acquire US company Timber Pharmaceuticals
Leo Pharma has entered an agreement for the acquisition of US-based clinical-stage biopharma firm Timber Pharmaceuticals for $36m.
Read the original article

Tags:

Previous Article

FDA grants approval for Pfizer’s RSV vaccine

Next Article

AI drug discovery company Genesis Therapeutics wins $200m in Series B round

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: We’re reading about FDA warnings on CAR-T drugs, a Sanofi deal, and more

STAT+: Pharmalittle: We’re reading about FDA warnings o...

Jan 24, 2024

Opinion: RSV vaccine approval should be a top priority for the FDA

Opinion: RSV vaccine approval should be a top priority ...

Apr 19, 2023

STAT+: New insights into how tumor cells hijack brain plasticity to drive cancer

STAT+: New insights into how tumor cells hijack brain p...

Nov 1, 2023